Minimal Residual Disease Testing After Stem Cell Transplantation for Multiple Myeloma

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2015.164
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC